EDITORIALS

Something Old, Something Few, Something Subjective, Something Déjà Vu

Sandra J. Horning

JCO Jan 1 2003: 1–2. [Full Text] [PDF]

The Ups and Downs of the Estrogen Receptor

V. Craig Jordan

JCO Jan 1 2003: 3–4. [Full Text] [PDF]

ORIGINAL REPORTS
Hematologic Malignancies
	Prolonged Single-Agent Versus Combination Chemotherapy in Indolent Follicular Lymphomas: A Study of the Cancer and Leukemia Group B
	Bruce A. Peterson, Gina R. Petroni, Glauco Frizzera, Maurice Barcos, Clara D. Bloomfield, Nis I. Nissen, David D. Hurd, Edward S. Henderson, George P. Sartiano, Jeffrey L. Johnson, James F. Holland, and Arlan J. Gottlieb
	JCO Jan 1 2003: 5–15. [Abstract] [Full Text] [PDF]
	Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma
	Donna Weber, Kim Rankin, Maria Gavino, Kay Delasalle, and Raymond Alexanian
	JCO Jan 1 2003: 16–19. [Abstract] [Full Text] [PDF]
	Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group
	E. Zucca, A. Conconi, T.I. Mughal, A.H. Sarris, J.F. Seymour, U. Vitolo, R. Klasa, M. Ozsahin, G.M. Mead, M.A. Gianni, S. Cortelazzo, A.J.M. Ferreri, A. Ambrosetti, M. Martelli, C. Thiéblemont, H. Gomez Moreno, G. Pinotti, G. Martinelli, R. Mozzana, S. Grisanti, M. Provencio, M. Balzarotti, F. Laveder, G. Oltean, V. Callea, P. Roy, F. Cavalli, and M.K. Gospodarowicz
	JCO Jan 1 2003: 20–27. [Abstract] [Full Text] [PDF]

Breast Cancer
	Incidence of Invasive Breast Cancer by Hormone Receptor Status From 1992 to 1998
	Christopher I. Li, Janet R. Daling, and Kathleen E. Malone
	JCO Jan 1 2003: 28–34. [Abstract] [Full Text] [PDF]
	Phase II Study of Oral Vinorelbine in First-Line Advanced Breast Cancer Chemotherapy
	G. Freyer, T. Delozier, M. Lichinister, D. Gedouin, P. Bougnoux, P. His, K. Imadalou, and V. Trillet-Lenoir
	JCO Jan 1 2003: 35–40. [Abstract] [Full Text] [PDF]
	High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer
	N. Hoogerbrugge, P. Bult, L.M. de Widt-Levert, L.V. Beex, L.A. Kiemeney, M.J.L. Ligtenberg, L.F. Massuger, C. Boetes, P. Manders, and H.G. Brunner
	JCO Jan 1 2003: 41–45. [Abstract] [Full Text] [PDF]
	Preoperative Therapy With Trastuzumab and Paclitaxel Followed by Sequential Adjuvant Doxorubicin/Cyclophosphamide for HER2 Overexpressing Stage II or III Breast Cancer: A Pilot Study
	Harold J. Burstein, Lyndsay N. Harris, Rebecca Gelman, Susan C. Lester, Raquel A. Nunes, Carolyn M. Kaelin, Leroy M. Parker, Leif W. Ellisen, Irene Kuter, Michele A. Gadd, Roger L. Christian, Patricia Rae Kennedy, Virginia F. Borges, Craig A. Bunnell, Jerry Younger, Barbara L. Smith, and Eric P. Winer
	JCO Jan 1 2003: 46–53. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)
	Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao, Narikazu Boku, Ichinosuke Hyodo, Hiroshi Saito, Noboru Yamamichi, Yoshinori Miyata, Nobumasa Ikeda, Seiichiro Yamamoto, Haruhiko Fukuda, and Shigeaki Yoshida
	JCO Jan 1 2003: 54–59. [Abstract] [Full Text] [PDF]
	Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer
	Fairooz Kabbinavar, Herbert I. Hurwitz, Louis Fehrenbacher, Neal J. Meropol, William F. Novotny, Grazyna Lieberman, Susan Griffing, and Emily Bergsland
	JCO Jan 1 2003: 60–65. [Abstract] [Full Text] [PDF]
	Combining Capecitabine and Gemcitabine in Patients With Advanced Pancreatic Carcinoma: A Phase I/II Trial
	Viviane Hess, Marc Salzberg, Markus Borner, Rudolf Morant, Arnaud D. Roth, Christian Ludwig, and Richard Herrmann
	JCO Jan 1 2003: 66–68. [Abstract] [Full Text] [PDF]

Lung Cancer
	Depression and Psychological Distress in Patients During the Year After Curative Resection of Non–Small-Cell Lung Cancer
	Yosuke Uchitomi, Ichiro Mikami, Kanji Nagai, Yutaka Nishiwaki, Tatsuo Akechi, and Hitoshi Okamura
	JCO Jan 1 2003: 69–77. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV
	John C. Breneman, Elizabeth Lyden, Alberto S. Pappo, Michael P. Link, James R. Anderson, David M. Parham, Stephen J. Qualman, Moody D. Wharam, Sarah S. Donaldson, Harold M. Maurer, William H. Meyer, K. Scott Baker, Charles N. Paidas, and William M. Crist
	JCO Jan 1 2003: 78–84. [Abstract] [Full Text] [PDF]
	Increased Risk of Systemic Relapses Associated With Bone Marrow Micrometastasis and Circulating Tumor Cells in Localized Ewing Tumor
	Gudrun Schleiermacher, Martine Peter, Odile Oberlin, Thierry Philip, Hervé Rubie, Françoise Mechinaud, Danièle Sommelet-Olive, Judith Landman-Parker, Danièle Bours, Jean Michon, and Olivier Delattre
	JCO Jan 1 2003: 85–91. [Abstract] [Full Text] [PDF]

Head and Neck Cancer
	An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
	David J. Adelstein, Yi Li, George L. Adams, Henry Wagner, Jr, Julie A. Kish, John F. Ensley, David E. Schuller, and Arlene A. Forastiere
	JCO Jan 1 2003: 92–98. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Prostate-Specific Antigen Kinetics as a Measure of the Biologic Effect of Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Serologic Progression of Prostate Cancer
	Brian I. Rini, Vivian Weinberg, Robert Bok, and Eric J. Small
	JCO Jan 1 2003: 99–105. [Abstract] [Full Text] [PDF]
	Differential Expression of S100A2 and S100A4 During Progression of Human Prostate Adenocarcinoma
	Sanjay Gupta, Tajamul Hussain, Gregory T. MacLennan, Pingfu Fu, Jigar Patel, and Hasan Mukhtar
	JCO Jan 1 2003: 106–112. [Abstract] [Full Text] [PDF]
	Update on Late Relapse of Germ Cell Tumor: A Clinical and Molecular Analysis
	David W. George, Richard S. Foster, Robert A. Hromas, Kent A. Robertson, Gail H. Vance, Thomas M. Ulbright, Troy A. Gobbett, Devan J. Heiber, Nyla A. Heerema, Heather C. Ramsey, Virginia C. Thurston, Sin-Ho Jung, Jianzhao Shen, David E. Finch, Mark R. Kelley, and Lawrence H. Einhorn
	JCO Jan 1 2003: 113–122. [Abstract] [Full Text] [PDF]
	Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer
	Tomasz M. Beer, Kristine M. Eilers, Mark Garzotto, Merrill J. Egorin, Bruce A. Lowe, and W. David Henner
	JCO Jan 1 2003: 123–128. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Effect of Fish Oil on Appetite and Other Symptoms in Patients With Advanced Cancer and Anorexia/Cachexia: A Double-Blind, Placebo-Controlled Study
	Eduardo Bruera, Florian Strasser, J. Lynn Palmer, Jie Willey, Kathryn Calder, Gail Amyotte, and Vickie Baracos
	JCO Jan 1 2003: 129–134. [Abstract] [Full Text] [PDF]

Immunotherapy
	Dendritic Cell-Based Vaccination in Solid Cancer
	A. Stift, J. Friedl, P. Dubsky, T. Bachleitner-Hofmann, G. Schueller, T. Zontsich, T. Benkoe, K. Radelbauer, C. Brostjan, R. Jakesz, and M. Gnant
	JCO Jan 1 2003: 135–142. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Phase I Clinical Trial of Intrathecal Topotecan in Patients With Neoplastic Meningitis
	Susan M. Blaney, Richard Heideman, Stacey Berg, Peter Adamson, Andy Gillespie, J. Russell Geyer, Roger Packer, Kate Matthay, Kurt Jaeckle, Diane Cole, Nancy Kuttesch, David G. Poplack, and Frank M. Balis
	JCO Jan 1 2003: 143–147. [Abstract] [Full Text] [PDF]
	A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies
	Eric K. Rowinsky, Jinee Rizzo, Leonel Ochoa, Chris H. Takimoto, Bahram Forouzesh, Garry Schwartz, Lisa A. Hammond, Amita Patnaik, Joseph Kwiatek, Andrew Goetz, Louis Denis, Jeffrey McGuire, and Anthony W. Tolcher
	JCO Jan 1 2003: 148–157. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Chemoprevention of Melanoma: An Unexplored Strategy
	Marie-France Demierre and Larry Nathanson
	JCO Jan 1 2003: 158–165. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Uncommon Syndromes and Treatment Manifestations of Malignancy: Case 1. Unusual Association of Lupus and Sarcoma

G. Rossi, M. Lucioni, L. Sammarchi, M. Paulli, G. Beluffi, A. Martini, and A. Ravelli

JCO Jan 1 2003: 166–167. [Full Text] [PDF]

Uncommon Syndromes and Treatment Manifestations of Malignancy: Case 2. Metastatic Non–Small-Cell Lung Cancer Presenting With Leukocytosis

Apar Kishor Ganti, Anil Potti, and Syed Mehdi

JCO Jan 1 2003: 168–170. [Full Text] [PDF]

Uncommon Syndromes and Treatment Manifestations of Malignancy: Case 3. Richter’s Syndrome Heralded by Refractory Hypercalcemia

Nancy J. Freeman and Debra Holik

JCO Jan 1 2003: 170–172. [Full Text] [PDF]

Uncommon Syndromes and Treatment Manifestations of Malignancy: Case 4. Periorbital Edema and Imatinib Mesylate Therapy for Chronic Myelogenous Leukemia

Kannan Ramar, Anil Potti, and Syed A. Mehdi

JCO Jan 1 2003: 172–173. [Full Text] [PDF]

ART OF ONCOLOGY

A Couple With Cancer: Conflicting Wishes, Joint Decisions

Bogda Koczwara and Matthew M. Clark

JCO Jan 1 2003: 174–176. [Full Text] [PDF]

SPECIAL DEPARTMENTS

CORRESPONDENCE

Boosting Bioavailability to Topotecan: What Do We Gain?

Franco M. Muggia and Gary R. Hudes

JCO Jan 1 2003: 177. [Full Text] [PDF]

Prognostic Value of Timing of Pulmonary Metastases Identification in Osteosarcoma Patients

Antonio Briccoli, Michele Rocca, Hiroyuki Tsuchiya, Mohamed Abdel-Wanis, Yoshimitsu Kanazawa, and Katsuro Tomita

JCO Jan 1 2003: 177-a–178. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.